By identifying strategic partners who share our values and vision to accelerate our growth in pharmaceuticals, we are happy to hand over our franchises. Right Now Our Franchises are open( For specific HQ send your Query), Products like Tablet, Capsules, Syrup/Suspension, Dry Powder, Injection,...
Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.Support View Site TipsHelp CentreContact UsAbout Us AccessibilitymyFT TourCareersSuppliers...
The Latest Updates on AUROPHARMA Share Price Aurobindo Pharma Ltd.’s share price as of 01 Feb 2025 is Rs.1,142.60. Over the past 6 months, Aurobindo Pharma Ltd.’s share price has decreased by 20.26% and in the last one year, it has increased by 6.71%. The 52-week low for Aurobi...
This presentation will share our perspective for achieving digital transformation and digital culture enablement, focusing on: Innovative solutions for meeting market demands and managing increasing complexity through integrated business process Opportunities for attaining new levels of operational excellence throug...
Entrepreneurs, who share our vision delivering excellent healthcare solutions can become a PCD franchise partner with the Kamron Group and join the network of dedicated healthcare professionals. Partnership with us is a straightforward deal. You can connect with our team for the initial enquiry and ...
Edward John Waring was the first to edit the first officially approved IP in 1868. The Indian pre-independence era was when BP was used. It was published in 1900 as an edition by the Government of India. As part of the Indian Pharmacopeial listpublished in 1946, the Indian Government publi...
Gujarat’s share in pharma exports is almost a quarter:... Prashant ChauhanMay 3, 20220107 Strategy India’s Pharma exports registers growth by 103% since 2013-14 Prashant ChauhanMay 2, 20220330 Industrial Player Section FDA Accepts Application for GSK’s Chronic Kidney Disease... ...
In financial year 2024, Gland Pharma Limited's total assets was valued at about 107 billion Indian rupees. This was an increase from the previous year where the value was nearly 88 billion Indian rupees. Total value of assets of Gland Pharma Limited from financial year 2019 to 2024 (in bill...
in R&D helped them to secure higher number of product approvals. The US market is key growth driver for Indian pharma companies and actions or ban on Indian products may impact working and share price movements. Several Indian pharma giants suffered heavily during 2017 due to the US FDA ...
Price in INR(Previous Close): 1802.650 Share Volume(Previous Close): 21,146 Price in INR(Last): 1794.550 52 Week Change: 562.150 90-Day Moving Average: 1839.344 Beta:0.547 52week High:1960.2 52week Low:1198.3537 50 Day Moving Average:1833.258 ...